This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: The Innovations of Ameet Vijay Ambarkhane
Introduction
Ameet Vijay Ambarkhane is a prominent inventor based in Horsham, Great Britain. With a track record of two patents, Ambarkhane has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that address inflammatory and metabolic disorders. His work focuses on innovative solutions that can potentially improve the quality of life for individuals suffering from various health conditions.
Latest Patents
Ambarkhane's latest patents showcase his prowess in pharmaceutical innovations. One notable patent is related to a choline salt of an anti-inflammatory substituted cyclobutenedione compound, specifically 6-chloro-3-[2-(1-ethyl-propylamino)-3,4-dioxo-cyclobut-1-enylamino]-2-hydroxy-N-methoxy-N-methyl-benzenesulfonamide choline. This invention includes solid pharmaceutical compositions and oral dosage forms that incorporate this compound, along with methods for treating individuals with inflammatory, obstructive, or allergic conditions.
Another patent features 3-spirocyclic piperidine derivatives as ghrelin receptor agonists. This invention encompasses derivatives formulated for potential therapeutic use, detailing processes for their preparation, pharmaceutical compositions that include these derivatives, and their application as medications for disorders linked to the ghrelin receptor.
Career Highlights
Ameet Vijay Ambarkhane is currently affiliated with Novartis AG, a leading global healthcare company. His tenure at Novartis has positioned him at the forefront of pharmaceutical innovation, allowing him to explore and develop groundbreaking solutions that align with the company's commitment to improving patient health.
Collaborations
Throughout his career, Ambarkhane has collaborated with esteemed colleagues, including Arnaud Mauler and Carsten Timpe. These partnerships have fostered an environment of shared knowledge and innovation, driving the development of new drugs and treatment modalities.
Conclusion
Ameet Vijay Ambarkhane represents a remarkable example of dedication and innovation in the pharmaceutical industry. His patents reflect a commitment to advancing medical science and improving patient outcomes. With a solid foundation at Novartis AG and valuable partnerships, Ambarkhane continues to impact the field through his inventive spirit and research-driven approach.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile